Xvivo Perfusion AB (XVIVO) - Total Liabilities

Latest as of March 2026: Skr299.60 Million SEK ≈ $32.24 Million USD

Based on the latest financial reports, Xvivo Perfusion AB (XVIVO) has total liabilities worth Skr299.60 Million SEK (≈ $32.24 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Xvivo Perfusion AB - Total Liabilities Trend (2011–2025)

This chart illustrates how Xvivo Perfusion AB's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Xvivo Perfusion AB to evaluate short-term liquidity relative to the company's equity base.

Xvivo Perfusion AB Competitors by Total Liabilities

The table below lists competitors of Xvivo Perfusion AB ranked by their total liabilities.

Company	Country	Total Liabilities
Barings BDC Inc NYSE:BBDC	USA	$1.48 Billion
CureVac NV F:5CV	Germany	€267.39 Million
Clevo Co TW:2362	Taiwan	NT$54.84 Billion
Mingyue Optical Lens Co.Ltd. SHE:301101	China	CN¥231.16 Million
China Building Material SHG:603060	China	CN¥3.08 Billion
Cementos Pacasmayo SAA ADR NYSE:CPAC	USA	$1.86 Billion
Appotronics Corp Ltd SHG:688007	China	CN¥1.03 Billion
Guangan SHG:600979	China	CN¥8.87 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Xvivo Perfusion AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Xvivo Perfusion AB worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xvivo Perfusion AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xvivo Perfusion AB (2011–2025)

The table below shows the annual total liabilities of Xvivo Perfusion AB from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr260.65 Million ≈ $28.05 Million	+5.97%
2024-12-31	Skr245.97 Million ≈ $26.47 Million	-1.84%
2023-12-31	Skr250.57 Million ≈ $26.96 Million	-17.29%
2022-12-31	Skr302.95 Million ≈ $32.60 Million	+17.81%
2021-12-31	Skr257.15 Million ≈ $27.67 Million	+81.28%
2020-12-31	Skr141.85 Million ≈ $15.27 Million	+149.00%
2019-12-31	Skr56.97 Million ≈ $6.13 Million	+23.48%
2018-12-31	Skr46.13 Million ≈ $4.96 Million	+34.87%
2017-12-31	Skr34.21 Million ≈ $3.68 Million	+4.03%
2016-12-31	Skr32.88 Million ≈ $3.54 Million	+70.33%
2015-12-31	Skr19.31 Million ≈ $2.08 Million	-24.34%
2014-12-31	Skr25.52 Million ≈ $2.75 Million	-17.50%
2013-12-31	Skr30.93 Million ≈ $3.33 Million	+20.10%
2012-12-31	Skr25.75 Million ≈ $2.77 Million	-80.03%
2011-12-31	Skr128.97 Million ≈ $13.88 Million	--

About Xvivo Perfusion AB

ST:XVIVO Sweden Medical Devices

Market Cap

$884.75 Million

Skr8.22 Billion SEK

Market Cap Rank

#9635 Global

#144 in Sweden

Share Price

Skr261.00

Change (1 day)

-3.48%

52-Week Range

Skr160.80 - Skr305.20

All Time High

Skr539.00